Yonglian Zeng

Statistics

Publications

Citations

462

H-Index

Active since

2015

Affiliations

First Affiliated Hospital of GuangXi Medical University(Current)

Guangxi Medical University

Central South University

Guilin Medical University

Xiangya Hospital Central South University

Yonglian Zeng is an author at First Affiliated Hospital of GuangXi Medical University specializing in oncology, life sciences, and molecular oncology.

ORCID

Publications per year

2015–2023

Publications

Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis

Fudi Zhong, Zhigao Hu, Keqing Jiang et al. · Cell Research · 2019 · 106 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

MicroRNA-1179 inhibits the proliferation, migration and invasion of human pancreatic cancer cells by targeting E2F5

Chengjie Lin, Zhigao Hu, Guandou Yuan et al. · Chemico-Biological Interactions · 2018 · 60 citations

Medicine, Molecular Biology, Oncology +12

Complement Inhibition Alleviates Cholestatic Liver Injury Through Mediating Macrophage Infiltration and Function in Mice

Zhenya Guo, Junze Chen, Yonglian Zeng et al. · Frontiers in Immunology · 2022 · 40 citations · Full text

Life Sciences, Immunology, Pathology +17

Low expression of B‐cell‐associated protein 31 in human primary hepatocellular carcinoma correlates with poor prognosis

Ning Tan, Qinyi Liu, Xiaojia Liu et al. · Histopathology · 2015 · 34 citations

Medicine, Oncology, Pathology +17

MicroRNA‐329‐mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma

Zhigao Hu, Chao‐Wen Zheng, Huizhao Su et al. · Journal of Cellular Biochemistry · 2018 · 34 citations

Life Sciences, Molecular Biology, Oncology +17

1–5 of 14